| Hypertension |
1 |
1 |
| Heart Failure (HF) |
0 |
0.79 |
| Myocardial Infarction (MI) |
0 |
0.67 |
| Blood |
0 |
0.63 |
| Antihypertensive Agents |
0 |
0.99 |
| Cardiovascular Risk Management |
0 |
0.32 |
| Adherence |
0 |
0.27 |
| Heart |
0 |
0.27 |
| Interference |
0 |
0.27 |
| Receptors |
0 |
0.27 |
| Acute Kidney Injury |
0 |
0.24 |
| Renal Failure |
0 |
0.21 |
| Orthostatic Hypotension |
0 |
0.19 |
| Hypotension |
0 |
0.18 |
| Kidney |
0 |
0.18 |
| Uncontrolled Hypertension |
0 |
0.18 |
| Cerebrovascular Accident |
0 |
0.12 |
| Adverse Effects |
0 |
0.09 |
| Cardiac Arrest |
0 |
0.09 |
| Clinical Research |
0 |
0.09 |
| Geriatrics |
0 |
0.09 |
| Injury |
0 |
0.09 |
| Plantar |
0 |
0.09 |
| Renin-Angiotensin System |
0 |
0.09 |
| Tissue |
0 |
0.09 |
| Healthcare and Medical Technology |
0 |
0.08 |
| Hyperkalemia |
0 |
0.08 |
| Patient Safety |
0 |
0.08 |
| Wound Management |
0 |
0.08 |